1
UPC_CFI_424/2023
ACT_586899/2023
CC_13509/2024 and
CC_13898/2024

ORDER
of the Court of First Instance of the Unified Patent Court
Local Division The Hague
issued on 29 January 2025

Dexcom Inc.
(Defendant) -
6340
Sequence
Drive - CA
92121-4356 -
San Diego -
US
Statement
of claim
served on
30/11/2023
Dexcom
International
Limited
(Defendant) -
1 Lampousas
Street - 1095
- Nicosia - CY
Statement
of claim
served on
20/12/2023

REFERENCE CODE ECLI: Not provided

CLAIMANT/S
1) Abbott Diabetes Care Inc.
(Claimant) - 1360 South Loop Road - CA 94502
- Alameda - US
Represented by Eelco
Bergsma

DEFENDANT/S
1) Dexcom Inc.
(Defendant) - 6340 Sequence Drive - CA
92121-4356 - San Diego - US
Represented by Tjibbe Douma
2) Dexcom International Limited
(Defendant) - 1 Lampousas Street - 1095 -
Nicosia - CY
Represented by Tjibbe Douma

PATENT AT ISSUE
Patent no. Proprietor/s
EP4070727 Abbott Diabetes Care Inc.

DECIDING JUDGES
Presiding judge Edger Brinkman
Judge-rapporteur Edger Brinkman

LANGUAGE OF PROCEEDINGS: English

SUBJECT-MATTER OF THE PROCEEDINGS
counter claims for revocation

GROUNDS
All parties to the proceedings requested withdrawal of their respective claims (above-mentioned
infringement claim and counter claims for revocation). By order of today, the full panel of the
court has allowed these withdrawals.
Dexcom’s request for reimbursement of 20% of the court fees can be allowed as well (R. 370.9).
In as far as necessary, the value of the actions is set at 4 million euro.

ORDER
The court:
- orders the claimant in the counter claims to be reimbursed 20% of the court fees paid, and
thus an amount of EUR 4.000.
- sets the value of the cases at EUR 4.000.000.

ORDER DETAILS
Order no. ORD_68862/2024 in ACTION NUMBER: ACT_586899/2023, CC_13509/2024 and
CC_13898/2024
UPC number: UPC_CFI_424/2023
Action type: Counter Claims for revocation
Related proceeding no. App_68474/2024, App_68465/2024 and App_68468/2024